25 studies found for:    Guillain-Barré Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Guillain-Barré Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting International Guillain-Barré Syndrome Outcome Study
Conditions: Guillain-Barré Syndrome;   Miller Fisher Syndrome
Intervention:
2 Completed Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
Condition: Guillain Barre Syndrome
Interventions: Drug: IVIG;   Procedure: Plasma Exchange
3 Unknown  Safety Study of GBS Following Menactra Meningococcal Vaccination
Condition: Guillain-Barre Syndrome
Intervention:
4 Completed Early Mechanical Ventilation for Guillain Barré Syndrome
Conditions: Guillain Barré Syndrome;   Acute Respiratory Failure
Interventions: Procedure: mechanical ventilation;   Procedure: physiotherapy and oxygen if needed
5 Unknown  The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation
Condition: Guillain Barré Syndrome
Intervention:
6 Completed Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-Aminopyridine
Condition: Guillain-Barre Syndrome
Intervention: Drug: 4-aminopyridine (4-AP)
7 Suspended Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Condition: Guillain-Barre Syndrome
Intervention: Drug: Immune globulin
8 Recruiting Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
Condition: Guillain-Barré Syndrome
Intervention: Drug: NPB-01
9 Completed Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
Conditions: Tetraplegia;   Respiratory Failure
Intervention:
10 Not yet recruiting Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Condition: Gullian Barre Syndrome
Intervention: Drug: Eculizumab
11 Completed Brain Computer Interface for Communication in ICU: a Feasibility Study
Conditions: Tetraplegia;   Guillain-Barre Syndrome
Intervention:
12 Recruiting Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
13 Recruiting Regional Citrate Anticoagulation in Plasma Exchange Treatment
Conditions: Focal Segmental Glomerulosclerosis;   Guillain-Barre Syndrome
Intervention: Procedure: plasma exchange treatment
14 Not yet recruiting Perception and Multisensory Integration in Neurological Patients Using fMRI
Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy;   Myasthenia Gravis;   Stroke;   Anosognosia;   Asomatognosia
Intervention: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla
15 Active, not recruiting Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
Condition: Observation Safety
Intervention:
16 Completed Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801
Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus (RRV) Vaccine
17 Active, not recruiting Cervarix Long-term Safety Surveillance
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix;   Other: Data collection
18 Active, not recruiting Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
Condition: Autoimmune Diseases in Subjects Receiving Cervarix®
Intervention: Other: Data collection
19 Active, not recruiting Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal conjugate vaccine GSK134612
20 Recruiting Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal vaccine GSK134612

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years